Eleonora Riccio Selected Research

Eleonora Riccio Research Topics

Disease

26	Fabry Disease (Fabry's Disease) 06/2022 - 11/2011
11	Autosomal Dominant Polycystic Kidney (ADPKD) 03/2022 - 05/2014
9	Chronic Renal Insufficiency 01/2020 - 01/2013
8	Inflammation (Inflammations) 03/2022 - 01/2012
6	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 01/2012
4	Pain (Aches) 12/2020 - 01/2013
4	Disease Progression 06/2020 - 12/2017
4	Proteinuria 01/2019 - 01/2013
3	Iron Deficiencies 01/2020 - 09/2013
3	Anemia 01/2020 - 09/2013
3	Acute Kidney Injury (Acute Renal Failure) 01/2016 - 01/2013
2	Polycystic liver disease 03/2022 - 12/2021
2	Hypertension (High Blood Pressure) 01/2020 - 05/2014
2	Fibrosis (Cirrhosis) 09/2019 - 12/2017
2	Left Ventricular Dysfunction 01/2019 - 12/2018
2	Neoplasms (Cancer) 01/2017 - 01/2015
2	Renal Insufficiency (Renal Failure) 01/2016 - 04/2015
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2016 - 05/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2022
1	Multiple Sclerosis 06/2022
1	Hyperkalemia 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2020
1	COVID-19 01/2020
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2020
1	Cysts 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Infections 01/2019
1	Rupture 01/2019
1	Urinary Tract Infections (Urinary Tract Infection) 01/2019
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018
1	Hypertrophy 12/2017
1	Carcinoma (Carcinomatosis) 02/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Microsatellite Instability 01/2017
1	Liver Diseases (Liver Disease) 01/2016

Drug/Important Bio-Agent (IBA)

8	GalactosidasesIBA 11/2018 - 11/2015
7	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2016
7	EnzymesIBA 11/2019 - 09/2013
6	Octreotide (Sandostatin)FDA LinkGeneric 03/2022 - 01/2016
6	Tolvaptan FDA Link 03/2022 - 05/2014
5	alpha-Galactosidase (Beano)IBA 06/2022 - 11/2011
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2022 - 01/2016
4	Pharmaceutical PreparationsIBA 06/2020 - 01/2013
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2021 - 01/2018
3	agalsidase beta FDA Link 01/2021 - 01/2015
3	agalsidase alfaIBA 12/2020 - 01/2015
3	GlycosphingolipidsIBA 06/2020 - 01/2018
3	IronIBA 01/2020 - 09/2013
3	4-cresol (p-cresol)IBA 06/2018 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 06/2016 - 01/2014
2	globotriaosylceramide (globotriosylceramide)IBA 06/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 06/2022 - 06/2018
2	globotriaosyl lysosphingolipidIBA 12/2020 - 11/2018
2	Metformin (Glucophage)FDA LinkGeneric 11/2019 - 10/2018
2	AlbuminsIBA 01/2019 - 01/2012
2	CreatinineIBA 01/2019 - 01/2019
2	LipidsIBA 06/2018 - 01/2013
2	Contrast MediaIBA 01/2016 - 01/2013
2	paricalcitol (Zemplar)FDA Link 04/2015 - 01/2015
1	CalciumIBA 03/2022
1	DNA (Deoxyribonucleic Acid)IBA 03/2022
1	1-dodecylpyridoxal (PLD)IBA 03/2022
1	theasinensin AIBA 12/2021
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021
1	migalastatIBA 12/2020
1	arylesteraseIBA 12/2020
1	AnticoagulantsIBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 11/2019
1	SphingolipidsIBA 09/2019
1	Valsartan (Vals)FDA Link 01/2019
1	benazepril (Briem)FDA LinkGeneric 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	MTOR InhibitorsIBA 10/2018
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 06/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 12/2017
1	Troponin IIBA 12/2017
1	3-Iodobenzylguanidine (Iobenguane)IBA 12/2017
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Proto-Oncogene Proteins c-metIBA 01/2017
1	Cadherins (E-Cadherin)IBA 01/2017

Therapy/Procedure

9	Therapeutics 03/2022 - 01/2013
7	Enzyme Replacement Therapy 12/2021 - 01/2013
3	Denervation 01/2020 - 05/2014
2	Renal Dialysis (Hemodialysis) 01/2020 - 01/2014
2	Sympathectomy (Sympathectomies) 12/2017 - 04/2016
2	Protein-Restricted Diet (Diet, Protein Restricted) 06/2016 - 04/2015
2	Peritoneal Dialysis 12/2013 - 01/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2022
1	Conservative Treatment 06/2018
1	Palliative Care (Palliative Therapy) 02/2017
1	Radiotherapy 02/2017
1	Diet Therapy (Therapy, Diet) 06/2016
1	Aftercare (After-Treatment) 01/2016